Skip to content
A9267Assembly2021-2022 SessionSame asS8191

Limit Step Therapy Rules

Official title

“Requires a utilization review agent to follow certain rules when establishing a step therapy protocol”

Sponsor John T. McDonald IIIAD-108+1 co-sponsorAffects Finance
Status
In Assembly Committee
Insurance
Impact
7/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Insurance

What's happening

This bill requires utilization review agents to follow strict new rules limiting step therapy protocols for prescription drugs in insurance plans.

Why it matters

  1. Limits on Step Therapy Barriers. The bill restricts how many different medications a patient must try and fail before getting coverage for the drug their doctor prescribes. This could reduce delays and frustration for patients needing timely, effective treatment, especially for those with chronic or complex conditions.

  2. Medical Expertise Prioritized. If a health care professional attests that a required drug has failed for a patient, that statement must be accepted as proof. This shifts authority toward the patient’s doctor and away from insurance companies, potentially leading to more individualized and effective care.

  3. Patient Protections Against Repetitive Protocols. The bill prevents insurers from forcing patients to repeat step therapy if they’ve already completed it under another plan or if they’ve used the prescribed drug within the past year. This helps ensure continuity of care and protects patients who switch insurance plans from unnecessary setbacks.

  4. Oversight and Enforcement. Any failure by insurers or utilization review agents to comply with these new requirements will automatically qualify patients for a step therapy override, making it easier to challenge and bypass restrictive or non-compliant insurance protocols. This provides a strong enforcement mechanism and recourse for patients and providers.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Health insurers and utilization review agents

    The bill would limit step therapy to one failed drug trial lasting no more than 30 days and prohibit requiring drugs not FDA-approved for the condition being treated.

  • Patients switching health plans

    The bill would prohibit requiring newly enrolled patients to repeat step therapy they already completed for the prescribed drug under a prior plan.

  • Treating health care professionals

    Utilization review agents would have to accept their attestations that a required drug failed as presumptive evidence of that failure.

  • Patients granted step therapy overrides

    The bill would require plans to honor override approvals until the later of 12 months after approval or plan renewal.

Headline styles

Limit Step Therapy Rules

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
John T. McDonald III

Assembly Member · Assembly District 108

Chair, Governmental Operations

1 Co-sponsor

History

  1. Referred to insurance

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S8191Senate

Limit Step Therapy Rules

In Assembly Committee · Insurance · Sponsor Neil D. Breslin

Impact 7 · Significant0% to pass

Full text

3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

9267

IN ASSEMBLY

February 9, 2022

Introduced by M. of A. McDONALD -- read once and referred to the Committee on Insurance

AN ACT to amend the insurance law and the public health law, in relation to requiring a utilization review agent to follow certain rules when establishing a step therapy protocol

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subsection (a) of section 4902 of the insurance law is amended by adding two new paragraphs 14 and 15 to read as follows:

(14) When establishing a step therapy protocol, a utilization review agent shall ensure that the protocol cannot:

(i) require a prescription drug that has not been approved by the United States Food and Drug Administration for the medical condition being treated;

(ii) require an insured to try and fail on more than one drug before providing coverage to the insured for the prescribed drug;

(iii) require the use of a step therapy-required drug for longer than thirty days;

(iv) be imposed on an insured if the insured has taken the prescribed drug covered by the plan within the past three hundred sixty-five days;

(v) require a newly enrolled insured to repeat step therapy for a prescribed drug where that insured already completed step therapy for that drug under a prior plan; and

(vi) be imposed on an insured for a prescribed drug that was previously approved for coverage by a plan for a specific medical condition after the insured's plan implements a formulary change that impacts the formulary status of the prescribed drug.

(15) When establishing a step therapy protocol, a utilization review agent shall ensure that the protocol accepts any attestation submitted by the insured's health care professional as defined in section four thousand nine hundred of this title stating that a required drug has failed as prima facie evidence that the required drug has failed.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD14433-01-2

§ 2. Subsections (c-3) and (g) of section 4903 of the insurance law, subsection (c-3) as added and subsection (g) as amended by chapter 512 of the laws of 2016, are amended to read as follows:

(c-3) Upon a determination that the step therapy protocol should be overridden, the health plan shall authorize immediate coverage for the prescription drug prescribed by the insured's treating health care professional. Any approval of a step therapy protocol override determination request shall be honored until the later of twelve months following the date of the approval or renewal of the plan.

(g) Failure by the utilization review agent to make a determination within the time periods prescribed in this section shall be deemed to be an adverse determination subject to appeal pursuant to section four thousand nine hundred four of this title, provided, however, that failure to meet such time periods for a step therapy protocol as defined in subsection (g-9) of section forty-nine hundred of this title or a step therapy protocol override determination pursuant to subsections (c-1), (c-2) and (c-3) of this section shall be deemed to be an override of the step therapy protocol. A utilization review agent's failure to comply with any of the step therapy protocol requirements required in subsections fourteen and fifteen of section four thousand nine hundred two of this title shall be considered a basis for granting an override of the step therapy protocol.

§ 3. Section 4902 of the public health law is amended by adding two new subdivisions 5 and 6 to read as follows:

5. When establishing a step therapy protocol, a utilization review agent shall ensure that the protocol cannot:

(a) require a prescription drug that has not been approved by the United States Food and Drug Administration for the medical condition being treated;

(b) require an enrollee to try and fail on more than one drug before providing coverage to the insured for the prescribed drug;

(c) require the use of a step therapy-required drug for longer than thirty days;

(d) be imposed on an enrollee if the enrollee has taken the prescribed drug covered by the plan within the past three hundred sixty-five days;

(f) require a newly enrolled enrollee to repeat step therapy for a prescribed drug where that enrollee already completed step therapy for that drug under a prior plan; and

(g) be imposed on an enrollee for a prescribed drug that was previously approved for coverage by a plan for a specific medical condition after the enrollee's plan implements a formulary change that impacts the formulary status of the prescribed drug.

6. When establishing a step therapy protocol, a utilization review agent shall ensure that the protocol accepts any attestation submitted by the enrollee's health care professional as defined in section fortynine hundred of this title stating that a required drug has failed as prima facie evidence that the required drug has failed.

§ 4. Subdivisions 3-c and 7 of section 4903 of the public health law, subdivision 3-c as added and subdivision 7 as amended by chapter 512 of the laws of 2016, are amended to read as follows:

3-c. Upon a determination that the step therapy protocol should be overridden, the health plan shall authorize immediate coverage for the prescription drug or drugs prescribed by the enrollee's treating health care professional. Any approval of a step therapy protocol override determination request shall be honored until the later of twelve months following the date of the approval or renewal of the plan.

7. Failure by the utilization review agent to make a determination within the time periods prescribed in this section shall be deemed to be an adverse determination subject to appeal pursuant to section fortynine hundred four of this title, provided, however, that failure to meet such time periods for a step therapy protocol as defined in subdivision seven-f-three of section forty-nine hundred of this title or a step therapy protocol override determination pursuant to subdivisions three-a, three-b and three-c of this section shall be deemed to be an override of the step therapy protocol. A utilization review agent's failure to comply with any of the step therapy protocol requirements required in subdivisions five and six of section forty-nine hundred two of this title shall be considered a basis for granting an override of the step therapy protocol.

§ 5. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.